Clinical Trials Logo

Clinical Trial Summary

The objective of this non-treatment, placebo-controlled, observational, 24-month follow-up study was to evaluate the long-term efficacy and safety of subcutaneous (SC) injections of deoxycholic acid (ATX-101) in the submental area. No treatment was administered in this study. Participants who previously received deoxycholic acid injections in studies ATX-101-10-16 [NCT01305577] or ATX-101-10-17 [NCT01294644] were enrolled in this non-treatment observational follow-up study to further evaluate safety and efficacy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03682471
Study type Observational
Source Allergan
Contact
Status Completed
Phase
Start date February 14, 2012
Completion date December 13, 2013

See also
  Status Clinical Trial Phase
Completed NCT04699669 - A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers Phase 1
Completed NCT02512822 - Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring N/A
Recruiting NCT06005441 - A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. Phase 2
Active, not recruiting NCT05736107 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat Phase 2
Not yet recruiting NCT03160976 - Cryolipolysis on Localized Adiposity N/A
Completed NCT03871556 - Diagnostic Ultrasound for Measuring Fat of the Body N/A
Completed NCT02098811 - Evaluation of the Safety and Precursors of Efficacy N/A
Active, not recruiting NCT04553627 - Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis N/A
Completed NCT02539043 - Effects of Ultrasound Cavitation Focused on Located Adiposity N/A
Completed NCT01842802 - Clinical Investigation of Non Invasive Fat Reduction N/A
Completed NCT04698642 - A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat Phase 2
Completed NCT02052622 - Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 Phase 3
Completed NCT04897412 - A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) Phase 2
Completed NCT05234736 - A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers Phase 2
Completed NCT04575467 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) Phase 2